Trials / Completed
CompletedNCT01127217
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
The Multicenter, Randomized, Double Blind Phase 3 Clinical Trial to Compare Efficacy and Safety of Combination of Amlodipine and Losartan Compared to Amlodipine Monotherapy in Patients With Stage 2 Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the blood pressure lowering effects of an amlodipine/losartan combination treatment and amlodipine monotherapy for treatment of Stage 2 hypertensive patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amlodipine/losartan | amlodipine 5mg/losartan 50mg, amlodipine 10mg/losartan 50mg (+HCTZ 12.5mg) |
| DRUG | amlodipine | amlodipine 5mg, amlodipine 10mg (+ HCTZ 12.5mg) |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-05-20
- Last updated
- 2010-09-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01127217. Inclusion in this directory is not an endorsement.